AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur has produced a sufficient supply of the adult and adolescent vaccine for tetanus and diphtheria, Tetanus and Diphtheria Toxoids Adsorbed For Adult Use (Td), to meet the nation's critical care and routine booster needs.
According to the U.S. Centers for Disease Control and Prevention's (CDC) Morbidity & Mortality Weekly Report (MMWR; June 21, 2002), this increase in supply has prompted the CDC to lift its year-long deferral, enabling physicians to now provide patients with routine Td boosters.
"Aventis Pasteur has been working for the past year to successfully end the national shortage of Td vaccine," said Michael Decker, MD, MPH, vice president, scientific and medical affairs at Aventis Pasteur. "Aventis Pasteur's efforts to relieve the shortage is an indication of the company's ability to meet the nation's need for Td vaccine now and in the future."
"With the return of ample tetanus and diphtheria vaccine supply, people who were asked to delay Td boosters during the last year should schedule appointments with their doctors to catch up," said William Schaffner, MD, professor and chairman, ...